180 related articles for article (PubMed ID: 12091294)
1. A three year follow up of preterm infants after moderately early treatment with dexamethasone.
Romagnoli C; Zecca E; Luciano R; Torrioli G; Tortorolo G
Arch Dis Child Fetal Neonatal Ed; 2002 Jul; 87(1):F55-8. PubMed ID: 12091294
[TBL] [Abstract][Full Text] [Related]
2. Controlled trial of early dexamethasone treatment for the prevention of chronic lung disease in preterm infants: a 3-year follow-up.
Romagnoli C; Zecca E; Luciano R; Torrioli G; Tortorolo G
Pediatrics; 2002 Jun; 109(6):e85. PubMed ID: 12042579
[TBL] [Abstract][Full Text] [Related]
3. Late (> 7 days) postnatal corticosteroids for chronic lung disease in preterm infants.
Doyle LW; Ehrenkranz RA; Halliday HL
Cochrane Database Syst Rev; 2014 May; (5):CD001145. PubMed ID: 24825542
[TBL] [Abstract][Full Text] [Related]
4. Early (< 8 days) postnatal corticosteroids for preventing chronic lung disease in preterm infants.
Doyle LW; Ehrenkranz RA; Halliday HL
Cochrane Database Syst Rev; 2014 May; (5):CD001146. PubMed ID: 24825456
[TBL] [Abstract][Full Text] [Related]
5. Delayed (>3 weeks) postnatal corticosteroids for chronic lung disease in preterm infants.
Halliday HL; Ehrenkranz RA
Cochrane Database Syst Rev; 2001; (2):CD001145. PubMed ID: 11405975
[TBL] [Abstract][Full Text] [Related]
6. Moderately early (7-14 days) postnatal corticosteroids for preventing chronic lung disease in preterm infants.
Halliday HL; Ehrenkranz RA
Cochrane Database Syst Rev; 2000; (2):CD001144. PubMed ID: 10796416
[TBL] [Abstract][Full Text] [Related]
7. Effect on growth of two different dexamethasone courses for preterm infants at risk of chronic lung disease. A randomized trial.
Romagnoli C; Zecca E; Vento G; Maggio L; Papacci P; Tortorolo G
Pharmacology; 1999 Nov; 59(5):266-74. PubMed ID: 10529659
[TBL] [Abstract][Full Text] [Related]
8. Update on Postnatal Steroids.
Halliday HL
Neonatology; 2017; 111(4):415-422. PubMed ID: 28538237
[TBL] [Abstract][Full Text] [Related]
9. Early postnatal (<96 hours) corticosteroids for preventing chronic lung disease in preterm infants.
Halliday HL; Ehrenkranz RA
Cochrane Database Syst Rev; 2000; (2):CD001146. PubMed ID: 10796252
[TBL] [Abstract][Full Text] [Related]
10. Delayed (>3 weeks) postnatal corticosteroids for chronic lung disease in preterm infants.
Halliday HL; Ehrenkranz RA
Cochrane Database Syst Rev; 2000; (2):CD001145. PubMed ID: 10796251
[TBL] [Abstract][Full Text] [Related]
11. Early postnatal dexamethasone treatment and increased incidence of cerebral palsy.
Shinwell ES; Karplus M; Reich D; Weintraub Z; Blazer S; Bader D; Yurman S; Dolfin T; Kogan A; Dollberg S; Arbel E; Goldberg M; Gur I; Naor N; Sirota L; Mogilner S; Zaritsky A; Barak M; Gottfried E
Arch Dis Child Fetal Neonatal Ed; 2000 Nov; 83(3):F177-81. PubMed ID: 11040164
[TBL] [Abstract][Full Text] [Related]
12. Postnatal corticosteroids in the treatment of chronic lung disease in the preterm infant: past, present, and future.
Nye J
Neonatal Netw; 2007; 26(5):293-9. PubMed ID: 17926659
[TBL] [Abstract][Full Text] [Related]
13. Structural and functional brain development after hydrocortisone treatment for neonatal chronic lung disease.
Lodygensky GA; Rademaker K; Zimine S; Gex-Fabry M; Lieftink AF; Lazeyras F; Groenendaal F; de Vries LS; Huppi PS
Pediatrics; 2005 Jul; 116(1):1-7. PubMed ID: 15995023
[TBL] [Abstract][Full Text] [Related]
14. Cardiac effects of short course dexamethasone in preterm infants.
Skelton R; Gill AB; Parsons JM
Arch Dis Child Fetal Neonatal Ed; 1998 Mar; 78(2):F133-7. PubMed ID: 9577285
[TBL] [Abstract][Full Text] [Related]
15. Controlled trial of dexamethasone in neonatal chronic lung disease: a 3-year follow-up.
Jones R; Wincott E; Elbourne D; Grant A
Pediatrics; 1995 Nov; 96(5 Pt 1):897-906. PubMed ID: 7478833
[TBL] [Abstract][Full Text] [Related]
16. Early postnatal dexamethasone for the prevention of chronic lung disease in high-risk preterm infants.
Romagnoli C; Zecca E; Vento G; De Carolis MP; Papacci P; Tortorolo G
Intensive Care Med; 1999 Jul; 25(7):717-21. PubMed ID: 10470576
[TBL] [Abstract][Full Text] [Related]
17. Effects of higher versus lower dexamethasone doses on pulmonary and neurodevelopmental sequelae in preterm infants at risk for chronic lung disease: a meta-analysis.
Onland W; De Jaegere AP; Offringa M; van Kaam AH
Pediatrics; 2008 Jul; 122(1):92-101. PubMed ID: 18595991
[TBL] [Abstract][Full Text] [Related]
18. A randomized trial of two dexamethasone regimens to reduce side-effects in infants treated for chronic lung disease of prematurity.
Odd DE; Armstrong DL; Teele RL; Kuschel CA; Harding JE
J Paediatr Child Health; 2004; 40(5-6):282-9. PubMed ID: 15151582
[TBL] [Abstract][Full Text] [Related]
19. Impaired cerebral cortical gray matter growth after treatment with dexamethasone for neonatal chronic lung disease.
Murphy BP; Inder TE; Huppi PS; Warfield S; Zientara GP; Kikinis R; Jolesz FA; Volpe JJ
Pediatrics; 2001 Feb; 107(2):217-21. PubMed ID: 11158449
[TBL] [Abstract][Full Text] [Related]
20. Postnatal hydrocortisone treatment for chronic lung disease in the preterm newborn and long-term neurodevelopmental follow-up.
Rademaker KJ; de Vries LS; Uiterwaal CS; Groenendaal F; Grobbee DE; van Bel F
Arch Dis Child Fetal Neonatal Ed; 2008 Jan; 93(1):F58-63. PubMed ID: 17848504
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
